Startups in biomedical research, drug development or biotechnology operate in a demanding environment. They work on innovative solutions, need to convince investors and at the same time meet strict regulatory requirements. Occupational safety and biosafety are often seen as necessary but complex obligations. FUTUROSALUD specialises in supporting startups with tailored concepts that reconcile safety and agility.
In young companies, resources are usually limited, responsibilities are shared and processes are in flux. FUTUROSALUD therefore starts with a pragmatic assessment: which projects are running, what laboratory equipment exists, which legal requirements apply and which documents already exist? On this basis, prioritised action plans are developed that align with the startup's growth stages.
Key elements are external occupational safety specialists and external biological safety officers. They bring expertise in ASiG, DGUV Regulation 2 and biotechnology law, and understand the typical phases of young technology companies. This allows realities from day-to-day projects to be aligned with regulatory expectations. FUTUROSALUD aims not to overwhelm startups with oversized structures but to build viable minimum standards that can be scaled.
The FUTUROSALUD ASI Manager helps startups organise risk assessments, training and measure tracking digitally. Especially in growing teams with changing roles, it is important to define responsibilities clearly and keep progress traceable. The platform also allows documents for investors, partners and authorities to be prepared efficiently, strengthening confidence in the company's professionalism.
With sector-specific templates, experienced specialists and a scalable digital platform, FUTUROSALUD helps startups establish occupational safety and biosafety on a solid footing from the start – as an integral part of a sustainable business model.
